Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Abstract A reduced incidence of nonmelanoma skin cancer among users of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARb) has been reported. A similar effect is suggested for cutaneous melanoma. We aimed to investigate the possible association between use of ACEi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer epidemiology 2009-11, Vol.33 (5), p.391-395
Hauptverfasser:	Koomen, E.R, Herings, R.M.C, Guchelaar, H.J, Nijsten, T
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE inhibitors Adolescent Adult Aged Angiotensin II type 1 receptor Antagonists Angiotensin II Type 1 Receptor Blockers - pharmacology Angiotensin-converting enzyme inhibitors Angiotensin-Converting Enzyme Inhibitors - pharmacology Cancer Epidemiology Female Hematology, Oncology and Palliative Medicine Humans Incidence Internal Medicine Male Melanoma Melanoma - epidemiology Middle Aged Skin Neoplasms - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!